VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
KMPR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
KMPRKemper Corporation
$27.31$1.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksKMPRQuarterly Financials

Kemper Corporation (KMPR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Kemper Corporation (KMPR) quarterly income statement — complete revenue, gross profit & net income history

KMPR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue1.11B1.14B1.24B1.23B1.19B1.18B1.17B1.14B1.14B1.18B1.19B1.25B1.29B1.37B1.35B1.38B1.35B1.45B1.43B1.48B
Revenue Growth %-6.82%-4.02%5.71%7.84%4.23%0.27%-1.74%-9.2%-11.57%-13.61%-12.08%-9.4%-4.31%-6.07%-5.59%-6.24%1.83%6.19%6.73%18.79%
Medical Costs & Claims828.8M854.5M1.24B1.13B1.05B1.36B908.8M1.18B1.16B959.7M1.13B1.16B1.2B1.25B1.27B1.34B1.31B1.47B1.4B1.4B
Medical Cost Ratio %74.74%75.23%100.04%91.79%88.52%114.82%77.74%103.24%101.94%81.32%94.97%92.14%93.18%91.75%93.7%96.94%97.35%100.88%97.48%95.06%
Gross Profit280.1M281.3M-500K100.8M136.6M-175.4M260.3M-36.9M-22.2M220.5M59.8M98.5M88.1M112.7M85.2M42.4M35.8M-12.8M36.1M72.9M
Gross Margin %25.26%24.77%-0.04%8.21%11.48%-14.82%22.26%-3.24%-1.94%18.68%5.03%7.86%6.82%8.25%6.3%3.06%2.65%-0.88%2.52%4.94%
Gross Profit Growth %105.05%260.38%-100.19%373.17%715.32%-179.55%335.28%-137.46%-125.2%95.65%-29.81%132.31%146.09%980.47%136.01%-41.84%-86.37%-103.83%-87.44%-77.64%
Operating Expenses288M294.8M32.6M13.3M16.8M-294.7M169.6M-128.8M-108.8M157M250.6M214.4M192M188.4M173M137M151.5M134.6M165.9M162.6M
OpEx / Revenue %25.97%25.96%2.64%1.08%1.41%-24.9%14.51%-11.31%-9.53%13.3%21.06%17.1%14.87%13.79%12.78%9.9%11.23%9.25%11.57%11.02%
Depreciation & Amortization11.6M-61.2M35.7M13M12.5M12.9M13.1M13.1M14.6M8.5M16M17.9M16.2M16M17.2M18.1M19.6M20.6M26.4M38.5M
Combined Ratio %100.71%101.19%102.68%92.87%89.93%89.92%92.24%91.93%92.41%94.62%116.04%109.24%108.05%105.54%106.49%106.84%108.58%110.13%109.05%106.08%
Operating Income-7.9M-13.5M-33.1M87.5M119.8M119.3M90.7M91.9M86.6M63.5M-190.8M-115.9M-103.9M-75.7M-87.8M-94.6M-115.7M-147.4M-129.8M-89.7M
Operating Margin %-0.71%-1.19%-2.68%7.13%10.07%10.08%7.76%8.07%7.59%5.38%-16.04%-9.24%-8.05%-5.54%-6.49%-6.84%-8.58%-10.13%-9.05%-6.08%
Operating Income Growth %-106.59%-111.32%-136.49%-4.79%38.34%87.87%147.54%179.29%183.35%183.88%-117.31%-22.52%10.2%48.64%32.36%-5.46%-195.15%-222.22%-185.34%-156.17%
EBITDA3.7M-74.7M2.6M100.5M132.3M132.2M103.8M105M101.2M72M-174.8M-98M-87.7M-59.7M-70.6M-76.5M-96.1M-126.8M-103.4M-51.2M
EBITDA Margin %0.33%-6.58%0.21%8.19%11.12%11.17%8.88%9.22%8.86%6.1%-14.69%-7.82%-6.79%-4.37%-5.22%-5.53%-7.12%-8.72%-7.21%-3.47%
Interest Expense9.3M9M9.1M9M11.4M14.6M14.4M13.9M14M13.9M14.1M14M14.1M13.7M14.3M14M12.7M10.6M10.7M11.2M
Non-Operating Income-9.3M29.5M-9.1M-9M-11.4M-14.6M-14.4M-13.9M-14M-13.9M-14.1M-14M-14.1M-13.7M-14.3M-14M-12.7M-10.6M-10.7M-11.2M
Pretax Income-7.9M-13.5M-33.1M87.5M119.8M119.3M90.7M91.9M86.6M63.5M-190.8M-115.9M-103.9M-75.7M-87.8M-94.6M-115.7M-147.4M-129.8M-89.7M
Pretax Margin %-0.71%-1.19%-2.68%7.13%10.07%10.08%7.76%8.07%7.59%5.38%-16.04%-9.24%-8.05%-5.54%-6.49%-6.84%-8.58%-10.13%-9.05%-6.08%
Income Tax-3.5M-3.5M-8.9M17.7M22.8M23.6M18.5M17.5M16.4M12.2M-44.4M-18.8M-23.8M-20.2M-13M-22.4M-29.4M-41.6M-54.5M-27.1M
Effective Tax Rate %44.3%25.93%26.89%20.23%19.03%19.78%20.4%19.04%18.94%19.21%23.27%16.22%22.91%26.68%14.81%23.68%25.41%28.22%41.99%30.21%
Net Income-1.7M-8M-21M72.6M99.7M97.4M73.7M75.4M71.3M51.4M-146.3M-97.1M-80.1M-55.5M-74.8M-72.2M-86.3M-105.8M-75.3M-62.6M
Net Margin %-0.15%-0.7%-1.7%5.91%8.38%8.23%6.3%6.62%6.25%4.36%-12.3%-7.74%-6.2%-4.06%-5.53%-5.22%-6.4%-7.27%-5.25%-4.24%
Net Income Growth %-101.71%-108.21%-128.49%-3.71%39.83%89.49%150.38%177.65%189.01%192.61%-95.59%-34.49%7.18%47.54%0.66%-15.34%-170.05%-208.51%-161.57%-149.64%
EPS (Diluted)-0.07-0.14-0.341.121.541.511.141.161.100.80-2.98-1.52-1.25-0.87-1.19-1.17-1.49-1.66-1.18-0.97
EPS Growth %-104.86%-109.27%-129.82%-3.45%40%88.75%138.25%176.32%188%191.95%-150.42%-29.91%16.11%47.59%-0.85%-20.62%-180.54%-213.7%-164.48%-150.79%
EPS (Basic)-0.07-0.14-0.341.131.561.531.151.171.110.80-2.98-1.52-1.25-0.87-1.19-1.17-1.49-1.66-1.18-0.97
Diluted Shares Outstanding58.8M58.8M61.48M64.6M64.63M64.63M64.9M64.89M64.77M64.57M64.06M64.01M63.95M63.89M63.85M63.82M63.74M63.65M63.63M64.38M